The Quality Payment Program (QPP) Performance Year 2018 Final Rule: Extended Flexibility on the Path to Value-Based Payments
The Centers for Medicare and Medicaid Services published a final rule with comment period on policies and requirements for physicians and other clinicians participating in the second year of the Quality Payment Program effective January 2018.
Healthcare & Life Sciences Institute Thu, 21 Dec 2017 00:00:00 GMT
Updating Medicare Parts C&D in response to market changes - The 2019 Medicare Part C&D Programs proposed rule
CMS issued a proposed rule for the Medicare Advantage and Part D programs that implements specific requirements in the Comprehensive Addiction and Recovery Act (CARA) and the 21st Century Cures Act (Cures).
Healthcare & Life Sciences Institute Wed, 10 Jan 2018 00:00:00 GMT
Demystifying Blockchain for Life Sciences - Blockchain could be a key to interoperability and privacy
Life Sciences is facing an unprecedented amount of data stemming from wearable, electronic health records and patient claims data. Pending regulations such as General Data Protection Regulation (GDPR) will only increase the focus on data privacy.
Healthcare & Life Sciences Institute Fri, 09 Mar 2018 00:00:00 GMT
Pricing for Survival: As demand for pharmaceutical cost containment intensifies, novel drug-pricing approaches are critical
Specialty drug costs are so high that the entire pharmaceutical industry is now under scrutiny for its pricing practices. In this piece, we explore the practical approaches to pricing for value that pharma manufacturers can leverage today.
Healthcare & Life Sciences Institute Mon, 26 Feb 2018 00:00:00 GMT
Healthcare’s silver lining: The industry’s stance on the Cloud is transitioning from fear to optimism
Is your healthcare organization under pressure to transition to a value-based model? Considering a merger or acquisition to realize cost and time efficiencies? Struggling with outdated legacy EHR systems? Losing sleep over emerging cyber risks? If so, it’s time to give serious consideration to...
Healthcare & Life Sciences Institute Fri, 23 Feb 2018 00:00:00 GMT
Advancing Payment Reform: Aligning MACRA payment model development with CMMI priorities
This paper explores the evolution of APMs since the passage of MACRA, examines barriers to new APM development and adoption, and raises questions about the limits of future APM proliferation.
Healthcare & Life Sciences Institute Mon, 26 Mar 2018 00:00:00 GMT
Revenue for the Life Sciences Industry: New standard. New challenges.
The new standard introduces a core principle that requires companies to evaluate their transactions in a new way. This publication summarizes the most significant issues for the Life Sciences industry.
Healthcare & Life Sciences Institute Sat, 24 Feb 2018 00:00:00 GMT
Wake Up Call: Healthcare providers and payers need to up their IT game. The clock is ticking
This whitepaper highlights the urgency for healthcare organizations to consider IT as a strategic priority in order to stay afloat in the midst of unimagined disruption and the need to maximize their IT investment strategies and optimize IT assets.
Healthcare & Life Sciences Institute Mon, 05 Mar 2018 00:00:00 GMT
What Works: The Triple Win - Rethinking Public Private Partnerships for Universal Healthcare
The time has come for universal health coverage (UHC); with unprecedented expansions in access to care across the world, global governments are looking to how private sector partners can contribute investment and skill to help them achieve it. Discover how to combine the lessons of the past...
Healthcare & Life Sciences Institute Thu, 22 Feb 2018 00:00:00 GMT
Future of Finance in Healthcare: Finance disrupted - As the industry adjusts to continuous disruption, the finance function has an opportunity to lead
The healthcare industry is experiencing unprecedented financial pressures in the midst of new and changing regulations, rising operating costs and reduced reimbursements for care delivery. CEOs are looking to the finance function to take on a considerably broader and deeper set of strategic...
Healthcare & Life Sciences Institute Thu, 26 Apr 2018 00:00:00 GMT
The disruption challenge: As new entrants and cross-sector models abound, which direction should healthcare organizations turn?
The pace of disruptive healthcare deals today – and the dollar value they represent – will fundamentally change how healthcare will look in the future.
Healthcare & Life Sciences Institute Tue, 17 Apr 2018 00:00:00 GMT
Data Governance – Driving Value in Healthcare
Data is now one of the most valuable assets in any organization, especially as healthcare transitions into a more digitally-driven industry. Demystifying data governance, and articulating its importance in realizing value for patients and carers, is a key pillar of any D&A strategy. KPMG has...
Healthcare & Life Sciences Institute Mon, 09 Jul 2018 00:00:00 GMT
Insider Threat in Life Sciences: 2018 Program Benchmark Report
The mission critical information, assets and operations of life sciences organizations are coming under attack – from within. Dealing with threats from the inside, both intentional and unintentional actions from employees, contractors and third-parties, involves many new challenges such as...
Healthcare & Life Sciences Institute Fri, 29 Jun 2018 00:00:00 GMT
Harvey Nash/KPMG CIO Survey 2018 – Pharmaceuticals Industry Findings
This Pharmaceuticals industry snapshot provides survey responses from 59 IT leaders on some of the key topics, and highlights several areas where this industry’s responses differed significantly from those across all industries.
Healthcare & Life Sciences Institute Fri, 21 Sep 2018 00:00:00 GMT
Digital Health and Disruption in Diabetes: Identifying Opportunities for Life Sciences Manufacturers
Life sciences companies are well-positioned to identify digital health opportunities that most closely align with not only patients’ needs, but their own long-term growth objectives.
Healthcare & Life Sciences Institute Tue, 31 Jul 2018 00:00:00 GMT